Jude Samulski, AskBio
January 28, 2021 11:27 AM EST
People
Cell/Gene Tx

Bay­er and AskBio ex­pand grand gene ther­a­py am­bi­tions with new Parkin­son's pro­gram, top sci­en­tist

Jason Mast

Editor

It on­ly took 20 years, but Jude Samul­s­ki is fi­nal­ly turn­ing AskBio in­to a gene ther­a­py be­he­moth in the hills of North Car­oli­na.

The now …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times